NEUROENDOCRINE NEOPLASMS
Clinical trials for NEUROENDOCRINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASMS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat neuroendocrine cancer
Disease control Recruiting nowThis early-phase study tests a new drug called BI 764532 added to standard chemotherapy for people with advanced neuroendocrine carcinoma (NEC). The goal is to find a safe dose and see if the combination helps shrink tumors. About 55 adults whose cancers have a specific marker (D…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 01, 2026 15:42 UTC
-
New drug shows promise for rare cancer in large Real-World trial
Disease control Recruiting nowThis study looks at how well the drug surufatinib works for people with advanced neuroendocrine tumors, a type of cancer. About 350 adults will take the drug daily, either alone or with other treatments, and be monitored for tumor response, side effects, and quality of life. The …
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 01, 2026 15:41 UTC
-
New combo therapy aims to shrink Hard-to-Treat gut tumors
Disease control Recruiting nowThis study tests whether combining two drugs, Lutathera and Olaparib, can shrink neuroendocrine tumors in the pancreas or intestine that cannot be removed by surgery. About 56 adults will receive Lutathera by IV every 8 weeks and take Olaparib pills twice daily. The goal is to fi…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC